Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
August 2012 Volume 30 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August 2012 Volume 30 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Serine protease inhibitor A3 in atherosclerosis and aneurysm disease

  • Authors:
    • Dick Wågsäter
    • Daniel Johansson
    • Vincent Fontaine
    • Emina Vorkapic
    • Alexandra Bäcklund
    • Anton Razuvaev
    • Mikko I. Mäyränpää
    • Charlotta Hjerpe
    • Kenneth Caidahl
    • Anders Hamsten
    • Anders Franco-Cereceda
    • Johannes Wilbertz
    • Jesper Swedenborg
    • Xinghua Zhou
    • Per Eriksson
  • View Affiliations / Copyright

    Affiliations: Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, Vascular Surgery Section, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden, Wihuri Research Institute, Helsinki, Finland, Clinical Physiology Unit, Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, Cardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden, The Karolinska Center for Transgene Technologies, Stockholm, Sweden
  • Pages: 288-294
    |
    Published online on: May 9, 2012
       https://doi.org/10.3892/ijmm.2012.994
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Remodeling of extracellular matrix (ECM) plays an important role in both atherosclerosis and aneurysm disease. Serine protease inhibitor A3 (serpinA3) is an inhibitor of several proteases such as elastase, cathepsin G and chymase derived from mast cells and neutrophils. In this study, we investigated the putative role of serpinA3 in atherosclerosis and aneurysm formation. SerpinA3 was expressed in endothelial cells and medial smooth muscle cells in human atherosclerotic lesions and a 14-fold increased expression of serpinA3n mRNA was found in lesions from Apoe-/- mice compared to lesion-free vessels. In contrast, decreased mRNA expression (-80%) of serpinA3 was found in biopsies of human abdominal aortic aneurysm (AAA) compared to non-dilated aortas. Overexpression of serpinA3n in transgenic mice did not influence the development of atherosclerosis or CaCl2-induced aneurysm formation. In situ zymography analysis showed that the transgenic mice had lower cathepsin G and elastase activity, and more elastin in the aortas compared to wild-type mice, which could indicate a more stable aortic phenotype. Differential vascular expression of serpinA3 is clearly associated with human atherosclerosis and AAA but serpinA3 had no major effect on experimentally induced atherosclerosis or AAA development in mouse. However, serpinA3 may be involved in a phenotypic stabilization of the aorta.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1. 

GK HanssonA HermanssonThe immune system in atherosclerosisNat Immunol12204212201121321594

2. 

E ChokeG CockerillWR WilsonS SayedJ DawsonI LoftusMM ThompsonA review of biological factors implicated in abdominal aortic aneurysm ruptureEur J Vasc Endovasc Surg30227244200515893484

3. 

MI MayranpaaJA TrosienV FontaineM FolkessonM KaziP ErikssonJ SwedenborgU HedinMast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysmsJ Vasc Surg50388396200910.1016/j.jvs.2009.03.05519515525

4. 

T TsurudaJ KatoK HatakeyamaK KojimaM YanoY YanoK NakamuraF Nakamura-UchiyamaY MatsushimaT ImamuraAdventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysmCirc Res10213681377200818451339

5. 

DF KetelhuthM BackThe role of matrix metalloproteinases in atherothrombosisCurr Atheroscler Rep13162169201110.1007/s11883-010-0159-721271310

6. 

I BotM BotSH van HeiningenPJ van SantbrinkIM LankhuizenP HartmanS GruenerH HilpertTJ van BerkelJ FingerleEA BiessenMast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in apoe−/− miceCardiovasc Res89244252201110.1093/cvr/cvq26020693162

7. 

J SunJ ZhangJS LindholtGK SukhovaJ LiuA HeM AbrinkG PejlerRL StevensRW ThompsonCritical role of mast cell chymase in mouse abdominal aortic aneurysm formationCirculation120973982200919720934

8. 

K TsunemiS TakaiM NishimotoD JinM SakaguchiM MuramatsuA YudaS SasakiM MiyazakiA specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-n-[[3,4-dioxo- 1-phenyl-7-(2-pyridyloxy)]-2-heptyl]acetamide (nk3201), suppresses development of abdominal aortic aneurysm in hamstersJ Pharmacol Exp Ther3098798832004

9. 

P RotziusS ThamsO SoehnleinE KenneCN TsengNK BjorkstromKJ MalmbergL LindbomEE ErikssonDistinct infiltration of neutrophils in lesion shoulders in apoe−/− miceAm J Pathol177493500201010.2353/ajpath.2010.09048020472897

10. 

JR CohenL KeeganI SarfatiD DannaC IlardiL WiseNeutrophil chemotaxis and neutrophil elastase in the aortic wall in patients with abdominal aortic aneurysmsJ Invest Surg4423430199110.3109/089419391091411721777436

11. 

JL EliasonKK HannawaG AilawadiI SinhaJW FordMP DeograciasKJ RoelofsDT WoodrumTL EnnisPK HenkeNeutrophil depletion inhibits experimental abdominal aortic aneurysm formationCirculation112232240200510.1161/CIRCULATIONAHA.104.51739116009808

12. 

X HouardZ TouatV OllivierL LouedecM PhilippeU SebbagO MeilhacP RossignolJB MichelMediators of neutrophil recruitment in human abdominal aortic aneurysmsCardiovasc Res82532541200910.1093/cvr/cvp04819201759

13. 

AJ HorvathJA IrvingJ RossjohnRH LawSP BottomleyNS QuinseyRN PikePB CoughlinJC WhisstockThe murine orthologue of human antichymotrypsin: A structural paradigm for clade a3 serpinsJ Biol Chem2804316843178200510.1074/jbc.M50559820016141197

14. 

T ChandraR StackhouseVJ KiddKJ RobsonSL WooSequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin iiiBiochemistry2250555061198310.1021/bi00291a0016606438

15. 

NM SchechterLM JordanAM JamesBS CoopermanZM WangH RubinReaction of human chymase with reactive site variants of alpha 1-antichymotrypsin. Modulation of inhibitor versus substrate propertiesJ Biol Chem268236262363319938226889

16. 

S ForsythA HorvathP CoughlinA review and comparison of the murine alpha1-antitrypsin and alpha1-antichymotrypsin multigene clusters with the human clade a serpinsGenomics81336345200310.1016/S0888-7543(02)00041-112659817

17. 

AJ HorvathSL ForsythPB CoughlinExpression patterns of murine antichymotrypsin-like genes reflect evolutionary divergence at the serpina3 locusJ Mol Evol59488497200410.1007/s00239-004-2640-915638460

18. 

AC ChiouB ChiuWH PearceMurine aortic aneurysm produced by periarterial application of calcium chlorideJ Surg Res99371376200110.1006/jsre.2001.620711469913

19. 

D WagsaterC ZhuHM BjorckP ErikssonEffects of pdgf-c and pdgf-d on monocyte migration and mmp-2 and mmp-9 expressionAtherosclerosis202415423200910.1016/j.atherosclerosis.2008.04.05018573494

20. 

L FolkersenF van’t HooftE ChernogubovaHE AgardhGK HanssonU HedinJ LiskaAC SyvanenG Paulsson-BerneA Franco-CerecedaAssociation of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular diseaseCirc Cardiovasc Genet3365373201010.1161/CIRCGENETICS.110.94893520562444

21. 

M KaziJ ThybergP ReligaJ RoyP ErikssonU HedinJ SwedenborgInfluence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wallJ Vasc Surg3812831292200310.1016/S0741-5214(03)00791-214681629

22. 

LS AngWA BoivinSJ WilliamsH ZhaoT AbrahamK Carmine-SimmenBM McManusRC BleackleyDJ GranvilleSerpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysmCell Death Dis2e209201110.1038/cddis.2011.8821900960

23. 

C BoudierG GodeauW HornebeckL RobertJG BiethThe elastolytic activity of cathepsin G: An ex vivo study with dermal elastinAm J Respir Cell Mol Biol4497503199110.1165/ajrcmb/4.6.4971711351

24. 

KA HanceM TatariaSJ ZiporinJK LeeRW ThompsonMonocyte chemotactic activity in human abdominal aortic aneurysms: Role of elastin degradation peptides and the 67-kd cell surface elastin receptorJ Vasc Surg35254261200210.1067/mva.2002.120382

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wågsäter D, Johansson D, Fontaine V, Vorkapic E, Bäcklund A, Razuvaev A, Mäyränpää MI, Hjerpe C, Caidahl K, Hamsten A, Hamsten A, et al: Serine protease inhibitor A3 in atherosclerosis and aneurysm disease. Int J Mol Med 30: 288-294, 2012.
APA
Wågsäter, D., Johansson, D., Fontaine, V., Vorkapic, E., Bäcklund, A., Razuvaev, A. ... Eriksson, P. (2012). Serine protease inhibitor A3 in atherosclerosis and aneurysm disease. International Journal of Molecular Medicine, 30, 288-294. https://doi.org/10.3892/ijmm.2012.994
MLA
Wågsäter, D., Johansson, D., Fontaine, V., Vorkapic, E., Bäcklund, A., Razuvaev, A., Mäyränpää , M. I., Hjerpe, C., Caidahl, K., Hamsten, A., Franco-Cereceda, A., Wilbertz, J., Swedenborg, J., Zhou, X., Eriksson, P."Serine protease inhibitor A3 in atherosclerosis and aneurysm disease". International Journal of Molecular Medicine 30.2 (2012): 288-294.
Chicago
Wågsäter, D., Johansson, D., Fontaine, V., Vorkapic, E., Bäcklund, A., Razuvaev, A., Mäyränpää , M. I., Hjerpe, C., Caidahl, K., Hamsten, A., Franco-Cereceda, A., Wilbertz, J., Swedenborg, J., Zhou, X., Eriksson, P."Serine protease inhibitor A3 in atherosclerosis and aneurysm disease". International Journal of Molecular Medicine 30, no. 2 (2012): 288-294. https://doi.org/10.3892/ijmm.2012.994
Copy and paste a formatted citation
x
Spandidos Publications style
Wågsäter D, Johansson D, Fontaine V, Vorkapic E, Bäcklund A, Razuvaev A, Mäyränpää MI, Hjerpe C, Caidahl K, Hamsten A, Hamsten A, et al: Serine protease inhibitor A3 in atherosclerosis and aneurysm disease. Int J Mol Med 30: 288-294, 2012.
APA
Wågsäter, D., Johansson, D., Fontaine, V., Vorkapic, E., Bäcklund, A., Razuvaev, A. ... Eriksson, P. (2012). Serine protease inhibitor A3 in atherosclerosis and aneurysm disease. International Journal of Molecular Medicine, 30, 288-294. https://doi.org/10.3892/ijmm.2012.994
MLA
Wågsäter, D., Johansson, D., Fontaine, V., Vorkapic, E., Bäcklund, A., Razuvaev, A., Mäyränpää , M. I., Hjerpe, C., Caidahl, K., Hamsten, A., Franco-Cereceda, A., Wilbertz, J., Swedenborg, J., Zhou, X., Eriksson, P."Serine protease inhibitor A3 in atherosclerosis and aneurysm disease". International Journal of Molecular Medicine 30.2 (2012): 288-294.
Chicago
Wågsäter, D., Johansson, D., Fontaine, V., Vorkapic, E., Bäcklund, A., Razuvaev, A., Mäyränpää , M. I., Hjerpe, C., Caidahl, K., Hamsten, A., Franco-Cereceda, A., Wilbertz, J., Swedenborg, J., Zhou, X., Eriksson, P."Serine protease inhibitor A3 in atherosclerosis and aneurysm disease". International Journal of Molecular Medicine 30, no. 2 (2012): 288-294. https://doi.org/10.3892/ijmm.2012.994
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team